ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,728.40
-1.07%
S&P ASX All Technology
3,070.60
-1.05%
Brent Oil
81.115
-0.24%
US Dollar vs AUD
1.51485
0.00%
Bitcoin
67,366.01
-0.82%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. iBio Inc (IBIO)

  7. iBio Inc (IBIO) News

IBIO

iBio (IBIO)

iBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:IBIO
DateTimeSourceHeadlineSymbolCompany
20/05/202420:55Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
14/05/202406:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
14/05/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
14/05/202406:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:IBIOiBio Inc
14/05/202406:08Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
14/05/202406:05GlobeNewswire Inc.iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate UpdateAMEX:IBIOiBio Inc
27/03/202422:00GlobeNewswire Inc.iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesAMEX:IBIOiBio Inc
27/03/202410:35GlobeNewswire Inc.iBio Announces $15.0 Million Private PlacementAMEX:IBIOiBio Inc
26/02/202423:59Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
26/02/202423:45GlobeNewswire Inc.iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaAMEX:IBIOiBio Inc
22/02/202408:55Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
20/01/202408:36Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
17/01/202400:15GlobeNewswire Inc.iBio Announces Participation in 23rd Annual PepTalk ConferenceAMEX:IBIOiBio Inc
11/01/202405:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:IBIOiBio Inc
09/01/202408:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
05/01/202400:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:IBIOiBio Inc
26/12/202323:44Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
26/12/202323:15GlobeNewswire Inc.iBio Amends and Extends Maturity of Credit AgreementAMEX:IBIOiBio Inc
09/12/202308:17Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
07/12/202301:13Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
07/12/202300:59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:IBIOiBio Inc
06/12/202300:00GlobeNewswire Inc.iBio, Inc. Announces Pricing of $4.5 Million Public OfferingAMEX:IBIOiBio Inc
05/12/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:IBIOiBio Inc
01/12/202300:55Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:IBIOiBio Inc
29/11/202300:36Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
28/11/202309:20GlobeNewswire Inc.iBio Announces Reverse Stock SplitAMEX:IBIOiBio Inc
04/11/202307:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
01/11/202323:24GlobeNewswire Inc.iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 BispecificAMEX:IBIOiBio Inc
28/10/202307:29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:IBIOiBio Inc
26/10/202323:22Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:IBIOiBio Inc
 Showing the most relevant articles for your search:AMEX:IBIO

Your Recent History

BIT
UC78Q6
Unicredit Bank
LSE
0ND9
Marenave Schiffahrts
NASDAQ
FYDQOX
Strategic International ...
TSXV
PINE.UN
Pine Trail Real Estate I...
NASDAQ
EBACW
European Biotech Acquisi...
BIT
UC4CUM
Unicredit Bank
BIT
UC6Y59
Unicredit Bank
COIN
SCETH
Siacoin
HITB
BBCETH
TraDove B2Bcoin
LSE
10HS
Fed.rep.n.47s
AMEX
NIN
AMEX
IYM
iShares US Basic Materials
EU
E331T
E331T
DOWI
DJEUDIV
DJ Europe Select Dividen...
USOTC
CEUMF
Century Global Commodities (PK)
BIT
S29350
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved